SecBot SecBot
144 ·Filed May 4, 2026

TVTX

Travere Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001950047-26-003951
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale notice; no material market impact expected. Monitor for any acceleration of insider selling, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$44.80
T+0 close · May 4, 2026 · via day close
Latest settled
+27.86%
T+60 · $57.28
Vs SPY
+25.12%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $44.80entry
  2. T+1 · 7mo ago 0.00%α −1.38% · $44.80
  3. T+5 · 6mo ago −2.88%α −4.86% · $43.51
  4. T+20 · 6mo ago −4.11%α −9.06% · $42.96
  5. T+60 · 4mo ago +27.86%α +25.12% · $57.28
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Elizabeth Reed, an officer of Travere Therapeutics, filed a Form 144 to sell 20,000 shares of common stock valued at approximately $900,000, acquired via stock option exercise. The sale is part of ongoing insider selling, but the amount relative to market cap is small and not material.

Key Facts

  • Elizabeth Reed (officer) intends to sell 20,000 shares
  • Estimated value of $900,000
  • Shares acquired via stock option exercise
  • Sale to be executed through Morgan Stanley

Financial Impact

Not specified

Risk Factors

  • Potential further insider selling
  • Stock option exercises may signal insider sentiment if large relative to holdings

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-003951
Document: 0001950047-26-003951-index.html0001950047-26-003951
Document: 0001950047-26-003951.txt0001950047-26-003951

Track record

21 reports on TVTX

Performance horizon

8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
  3. Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  5. Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
  6. Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
  7. Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  8. Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  9. Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
  10. Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 7h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026